戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 sence of the reverse-transcriptase inhibitor azidothymidine.
2 inhibitors have been approved for human use: azidothymidine; 2'3'-dideoxycytidine; 2'3'-dideoxyinosin
3 tudy to demonstrate the on-demand release of azidothymidine 5'-triphosphate, an anti-human immunodefi
4                    Several other substrates, azidothymidine, 9-(2-phosphonylmethoxyethyl)adenine, and
5  found that pre-incubation of the cells with azidothymidine, a pro-oxidant drug, significantly improv
6 omal cell-derived factor-1 (for HIVIIIB), or azidothymidine added during the HIV pulse, as well as by
7 ely impaired the antiviral efficacy of PMEA, azidothymidine and other nucleoside analogs.
8 thymidine (d4T) >> (+)3TC >> (-)3TC > PMPA > azidothymidine (AZT) >> Carbovir (CBV).
9                           We have found that Azidothymidine (AZT) alone induces apoptosis in Epstein
10 kitt's lymphoma (BL) responded to parenteral azidothymidine (AZT) and IFN-alpha.
11          Sensitivity of radA recG mutants to azidothymidine (AZT) can be rescued by blocking recombin
12                                              Azidothymidine (AZT) caused progressive telomere shorten
13 ilylated nucleoside scaffold derived from 3'-azidothymidine (AZT) consistently and selectively inhibi
14 bination of interferon alpha (IFN-alpha) and azidothymidine (AZT) induces apoptosis in PEL cell lines
15               The antiviral thymidine analog azidothymidine (AZT) is used to treat several virus-asso
16 between muscle performance and CD4+ count or azidothymidine (AZT) use.
17  replication inhibitors hydroxyurea (HU) and azidothymidine (AZT) was suppressed by alleles of dnaA t
18                                           3'-Azidothymidine (AZT) was the first approved antiviral fo
19 ons to anti-HIV/AIDS pharmaceuticals such as azidothymidine (AZT), anti-malarial compounds and novel
20 stic interactions is with the antiviral drug azidothymidine (AZT).
21 troviral combinations that do not include 3'-azidothymidine (AZT).
22 as steeper in patients receiving zidovudine (azidothymidine [AZT], -3.64 g/dL vs. no AZT, -2.08 g/dL)
23 iency virus type 1 (HIV-1) to zidovudine (3'-azidothymidine; AZT) and appear to approximate the templ
24 lex formation, and primer terminated with 3'-azidothymidine formed dead-end complex with 25-fold elev
25 creased the cell toxicity of ganciclovir and azidothymidine in PEL cells but had no significant effec
26 M184V suppressed the excision of 3'-deoxy-3'-azidothymidine monophosphate (AZTMP) to a greater extent
27 EA (9-(2-phosphonylmethoxyethyl)adenine) and azidothymidine monophosphate from cells and, thus, with
28 e nucleoside reverse transcriptase inhibitor azidothymidine or the protease inhibitor indinavir to th
29  The combination of 6-TG and a RT inhibitor, azidothymidine, provided partial protection.
30 RNase H activity, in addition to the loss of azidothymidine resistance.
31 trains, and reverse transcriptase-resistant, azidothymidine-resistant, ddC/ddI-resistant, nivirapine-
32 se), which can phosphorylate ganciclovir and azidothymidine, respectively.
33  in some patients receiving 2',3'-dideoxy-3'-azidothymidine therapy in combination with 2',3'-dideoxy
34 violet light or 2,2'-dithiodipyridine and in azidothymidine-treated mice.
35 and the two nucleoside analog RT inhibitors (azidothymidine triphosphate or ddCTP), whereas two non-n
36 TP approximately alpha-thio-dTTP < dUTP < 3'-azidothymidine triphosphate).
37 ivity of several mutants was resistant to 3'-azidothymidine triphosphate.
38     When the reverse transcriptase inhibitor azidothymidine was added to the DCs during exposure to H
39                                              Azidothymidine was studied as an antineoplastic in the 1
40  the phosphorylated forms of ganciclovir and azidothymidine, we found that PEL cells exposed to hypox
41 ideoxyinosine, 2',3'-dideoxycytidine, and 3'-azidothymidine, which are known inhibitors of N1 or N2,
42 the accurate assessment of HIV inhibition by azidothymidine (zidovudine), dideoxycytidine (zalcytibin
43 vents, this study defines such a mutagen, 3'-azidothymidine [zidovudine (AZT)], used widely in the tr

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。